156 related articles for article (PubMed ID: 8768297)
1. [Autoimmunity and glutamate decarboxylase antibodies in the pathogenesis of type I diabetes mellitus in experimental and clinical practice].
Kucera P; Andĕl M; Treslová L
Vnitr Lek; 1996 May; 42(5):359-67. PubMed ID: 8768297
[TBL] [Abstract][Full Text] [Related]
2. Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes.
Hummel M; Durinovic-Bello I; Ziegler AG
J Autoimmun; 1996 Jun; 9(3):427-30. PubMed ID: 8816982
[TBL] [Abstract][Full Text] [Related]
3. [Detection of antibodies against pancreatic islet cells in clinical practice].
Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies to GAD65 and IA-2 in canine diabetes mellitus.
Davison LJ; Weenink SM; Christie MR; Herrtage ME; Catchpole B
Vet Immunol Immunopathol; 2008 Nov; 126(1-2):83-90. PubMed ID: 18706702
[TBL] [Abstract][Full Text] [Related]
5. [IA-2 and anti-GAD antibodies in patients with newly diagnosed type 1 diabetes and their first degree relatives].
Kretowski A; Kowalska I; Peczyńska J; Urban M; Kinalska I
Przegl Lek; 2000; 57(3):143-6. PubMed ID: 10909282
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin variable gene analysis of human autoantibodies reveals antigen-driven immune response to glutamate decarboxylase in type 1 diabetes mellitus.
Richter W; Jury KM; Loeffler D; Manfras BJ; Eiermann TH; Boehm BO
Eur J Immunol; 1995 Jun; 25(6):1703-12. PubMed ID: 7614998
[TBL] [Abstract][Full Text] [Related]
7. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes.
Honeyman MC; Stone N; de Aizpurua H; Rowley MJ; Harrison LC
J Autoimmun; 1997 Apr; 10(2):165-73. PubMed ID: 9185878
[TBL] [Abstract][Full Text] [Related]
8. [GAD antibody in IDDM].
Yokota I; Shima K
Rinsho Byori; 1998 Apr; 46(4):331-7. PubMed ID: 9594623
[TBL] [Abstract][Full Text] [Related]
9. Signs of beta-cell autoimmunity and HLA-defined diabetes susceptibility in the Finnish population: the sib cohort from the Type 1 Diabetes Prediction and Prevention Study.
Kukko M; Kimpimäki T; Kupila A; Korhonen S; Kulmala P; Savola K; Simell T; Keskinen P; Ilonen J; Simell O; Knip M
Diabetologia; 2003 Jan; 46(1):65-70. PubMed ID: 12637984
[TBL] [Abstract][Full Text] [Related]
10. [Prevalence and predictive value of GAD65 autoantibodies and their correlation with HLA DR-DQ genotypes in children with type-1 diabetes].
Hermann R; Gombos Z; Gyürüs E; Soltész G
Orv Hetil; 2003 Feb; 144(8):355-60. PubMed ID: 12666382
[TBL] [Abstract][Full Text] [Related]
11. [Latent autoimmune (Type-1) diabetes mellitus in adults. Part. I. Serologic markers of autoimmune involvement of pancreatic beta-cells: GADA, ICA, IA-2 a IA-A].
Martinka E; Ocenásová A; Straková J; Mokán M
Vnitr Lek; 1999 Feb; 45(2):97-102. PubMed ID: 15641228
[TBL] [Abstract][Full Text] [Related]
12. Specificity of islet cell autoantibodies and coexistence with other organ specific autoantibodies in type 1 diabetes mellitus.
Tsirogianni A; Pipi E; Soufleros K
Autoimmun Rev; 2009 Jul; 8(8):687-91. PubMed ID: 19217947
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and clinical characteristics of insulin-treated, anti-GAD-positive, type 2 diabetic subjects in an outpatient clinical department of a Dutch teaching hospital.
Römkens TE; Kusters GC; Netea MG; Netten PM
Neth J Med; 2006 Apr; 64(4):114-8. PubMed ID: 16609158
[TBL] [Abstract][Full Text] [Related]
14. Immune reactivity of diabetes-associated human monoclonal autoantibodies defines multiple epitopes and detects two domain boundaries in glutamate decarboxylase.
Syren K; Lindsay L; Stoehrer B; Jury K; Lühder F; Baekkeskov S; Richter W
J Immunol; 1996 Dec; 157(11):5208-14. PubMed ID: 8943434
[TBL] [Abstract][Full Text] [Related]
15. Autoimmunity to CD38 and GAD in Type I and Type II diabetes: CD38 and HLA genotypes and clinical phenotypes.
Antonelli A; Tuomi T; Nannipieri M; Fallahi P; Nesti C; Okamoto H; Groop L; Ferrannini E
Diabetologia; 2002 Sep; 45(9):1298-306. PubMed ID: 12242463
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies to GAD and IA-2 in Saudi Arabian diabetic patients.
Damanhouri LH; Dromey JA; Christie MR; Nasrat HA; Ardawi MS; Robins RA; Todd I
Diabet Med; 2005 Apr; 22(4):448-52. PubMed ID: 15787671
[TBL] [Abstract][Full Text] [Related]
17. GAD65-Reactive T cells in a non-diabetic stiff-man syndrome patient.
Schloot NC; Batstra MC; Duinkerken G; De Vries RR; Dyrberg T; Chaudhuri A; Behan PO; Roep BO
J Autoimmun; 1999 Jun; 12(4):289-96. PubMed ID: 10330300
[TBL] [Abstract][Full Text] [Related]
18. The possible role of autoimmunity in the pathogenesis of diabetes in B-thalassemia major.
Monge L; Pinach S; Caramellino L; Bertero MT; Dall'omo A; Carta Q
Diabetes Metab; 2001 Apr; 27(2 Pt 1):149-54. PubMed ID: 11353881
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
Whittingham S; Byron SL; Tuomilehto J; Zimmet PZ; Myers MA; Vidgren G; Rowley MJ; Feeney SJ; Koskela P; Tuomilehto-Wolf E; Mackay IR
Diabet Med; 1997 Aug; 14(8):678-85. PubMed ID: 9272595
[TBL] [Abstract][Full Text] [Related]
20. [Auto-antibodies against glutamic acid decarboxylase and diabetes].
Mandrup-Poulsen TR
Ugeskr Laeger; 2007 Jan; 169(4):300-4. PubMed ID: 17274923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
